Repligen
RGEN
#2078
Rank
โ‚น813.10 B
Marketcap
โ‚น14,445
Share price
-2.53%
Change (1 day)
10.27%
Change (1 year)
Categories

Repligen (RGEN) - Cash on Hand

Cash on Hand as of September 2025 : โ‚น67.25 Billion

According to Repligen 's latest financial reports the company has โ‚น67.25 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Repligen - Cash on Hand chart (from 1996 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-12-31โ‚น64.97 B3.88%
2023-12-31โ‚น62.54 B21.18%
2022-12-31โ‚น51.61 B14.85%
2021-12-31โ‚น44.94 B-14.33%
2020-12-31โ‚น52.45 B39.22%
2019-12-31โ‚น37.68 B178.03%
2018-12-31โ‚น13.55 B22.15%
2017-12-31โ‚น11.09 B15.15%
2016-12-31โ‚น9.63 B101.99%
2015-12-31โ‚น4.76 B28.75%
2014-12-31โ‚น3.70 B-2.69%
2013-12-31โ‚น3.80 B73.59%
2012-12-31โ‚น2.19 B
2011-03-31โ‚น2.20 B-6.92%
2010-03-31โ‚น2.36 B-4.04%
2009-03-31โ‚น2.46 B23.78%
2008-03-31โ‚น1.99 B104.22%
2007-03-31โ‚น0.97 B15.44%
2006-03-31โ‚น0.84 B13.07%
2005-03-31โ‚น0.74 B23.66%
2004-03-31โ‚น0.60 B-18.03%
2003-03-31โ‚น0.73 B-27.42%
2002-03-31โ‚น1.01 B-8.89%
2001-03-31โ‚น1.11 B-24.79%
2000-03-31โ‚น1.48 B959.72%
1999-03-31โ‚น0.14 B-24.6%
1998-03-31โ‚น0.18 B47.95%
1997-03-31โ‚น0.12 B-46.86%
1996-03-31โ‚น0.23 B

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Novavax
NVAX
โ‚น68.52 B 1.89%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
โ‚น132.74 B 97.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
โ‚น100.13 B 48.89%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
โ‚น1.213 T 1,704.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚น318.51 B 373.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
โ‚น1.482 T 2,103.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น1.345 T 1,901.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
โ‚น13.02 B-80.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
โ‚น2.66 B-96.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
โ‚น18.60 B-72.34%๐Ÿ‡บ๐Ÿ‡ธ USA